InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Franson Timothy R, Director. Director active across 2 companies, notably Cidara Therapeutics, Inc.. In total, 5 disclosures have been logged. Split: 1 buy · 1 sell. Total volume traded: €25k. Activity tracked since 13 September 2021. The latest transaction was filed on 21 February 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Franson Timothy R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
52,000 sharesCommon StockSEC:0000899243-23-019355:0
7,000 shares@ US$1.88100.0% of flowCommon StockSEC:0000904454-23-000176:0
20,000 shares0Common StockSEC:0000904454-23-000103:0
20,000 shares0Common StockSEC:0000904454-22-000165:0
7,000 shares@ US$2.1175100.0% of flowCommon StockSEC:0001610618-21-000084:0
Canonical exit: 12 Dec 2021 (T+90)
5 of 5 declarations
About Franson Timothy R
Timothy R. Franson is a Board Member at Cidara Therapeutics, Inc. and Paratek Pharmaceuticals, Inc. He brings his expertise to the board, contributing to strategic decision-making for these companies. His role includes overseeing operations and protecting shareholder interests. Through his experience, he helps guide the future direction of the companies.
